271 related articles for article (PubMed ID: 15954913)
21. The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study.
Atthobari J; Brantsma AH; Gansevoort RT; Visser ST; Asselbergs FW; van Gilst WH; de Jong PE; de Jong-van den Berg LT;
Nephrol Dial Transplant; 2006 Nov; 21(11):3106-14. PubMed ID: 16720593
[TBL] [Abstract][Full Text] [Related]
22. Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S).
Huskey J; Lindenfeld J; Cook T; Targher G; Kendrick J; Kjekshus J; Pedersen T; Chonchol M
Atherosclerosis; 2009 Jul; 205(1):202-6. PubMed ID: 19124121
[TBL] [Abstract][Full Text] [Related]
23. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia.
Li JJ; Li YS; Chu JM; Zhang CY; Wang Y; Huang Y; Chen J; Yuan JQ; Huang YL
Clin Chim Acta; 2006 Apr; 366(1-2):269-73. PubMed ID: 16343471
[TBL] [Abstract][Full Text] [Related]
24. Anti-inflammatory interventions in end-stage kidney disease: a randomized, double-blinded, controlled and crossover clinical trial on the use of pravastatin in continuous ambulatory peritoneal dialysis.
Cueto-Manzano AM; Angel-Zúñiga JR; Ornelas-Carrillo G; Rojas-Campos E; Martínez-Ramírez HR; Cortés-Sanabria L
Arch Med Res; 2013 Nov; 44(8):633-7. PubMed ID: 24211751
[TBL] [Abstract][Full Text] [Related]
25. Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome.
Mielniczuk LM; Pfeffer MA; Lewis EF; Blazing MA; de Lemos JA; Shui A; Mohanavelu S; Califf RM; Braunwald E
Am Heart J; 2008 Apr; 155(4):725-31. PubMed ID: 18371483
[TBL] [Abstract][Full Text] [Related]
26. Inflammation and oxidation: do they improve after kidney transplantation? Relationship with mortality after transplantation.
Cañas L; Iglesias E; Pastor MC; Barallat J; Juega J; Bancu I; Lauzurica R
Int Urol Nephrol; 2017 Mar; 49(3):533-540. PubMed ID: 28013471
[TBL] [Abstract][Full Text] [Related]
27. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
[TBL] [Abstract][Full Text] [Related]
28. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease.
Menon V; Greene T; Wang X; Pereira AA; Marcovina SM; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
Kidney Int; 2005 Aug; 68(2):766-72. PubMed ID: 16014054
[TBL] [Abstract][Full Text] [Related]
29. Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Baimbridge C; Davis BR; Barzilay J; Basile JN; Henriquez MA; Huml A; Kopyt N; Louis GT; Pressel SL; Rosendorff C; Sastrasinh S; Stanford C;
Am J Kidney Dis; 2008 Sep; 52(3):412-24. PubMed ID: 18676075
[TBL] [Abstract][Full Text] [Related]
30. Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR.
Matsushita K; Tonelli M; Lloyd A; Levey AS; Coresh J; Hemmelgarn BR;
Am J Kidney Dis; 2012 Aug; 60(2):241-9. PubMed ID: 22560843
[TBL] [Abstract][Full Text] [Related]
31. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.
Oberg BP; McMenamin E; Lucas FL; McMonagle E; Morrow J; Ikizler TA; Himmelfarb J
Kidney Int; 2004 Mar; 65(3):1009-16. PubMed ID: 14871421
[TBL] [Abstract][Full Text] [Related]
32. White blood cell count predicts reduction in coronary heart disease mortality with pravastatin.
Stewart RA; White HD; Kirby AC; Heritier SR; Simes RJ; Nestel PJ; West MJ; Colquhoun DM; Tonkin AM;
Circulation; 2005 Apr; 111(14):1756-62. PubMed ID: 15809366
[TBL] [Abstract][Full Text] [Related]
33. Greater posttransplant inflammation and oxidation are associated with worsening kidney function in patients with pretransplant diabetes mellitus.
Morales-Indiano C; Lauzurica R; Pastor MC; Bayés B; Sancho A; Troya M; Romero R
Transplant Proc; 2009; 41(6):2126-8. PubMed ID: 19715851
[TBL] [Abstract][Full Text] [Related]
34. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease.
Eustace JA; Astor B; Muntner PM; Ikizler TA; Coresh J
Kidney Int; 2004 Mar; 65(3):1031-40. PubMed ID: 14871424
[TBL] [Abstract][Full Text] [Related]
36. Association between markers of renal function and C-reactive protein level in the elderly: confounding by functional status.
Wasén E; Isoaho R; Vahlberg T; Kivelä SL; Irjala K
Scand J Clin Lab Invest; 2008; 68(6):484-91. PubMed ID: 18609082
[TBL] [Abstract][Full Text] [Related]
37. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
[TBL] [Abstract][Full Text] [Related]
38. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.
Ridker PM; Rifai N; Pfeffer MA; Sacks FM; Moye LA; Goldman S; Flaker GC; Braunwald E
Circulation; 1998 Sep; 98(9):839-44. PubMed ID: 9738637
[TBL] [Abstract][Full Text] [Related]
39. Pravastatin and cardiovascular risk in moderate chronic kidney disease.
Nakamura H; Mizuno K; Ohashi Y; Yoshida T; Hirao K; Uchida Y;
Atherosclerosis; 2009 Oct; 206(2):512-7. PubMed ID: 19423108
[TBL] [Abstract][Full Text] [Related]
40. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
